Illumina stock gains as 2026 guidance rises
Published on 09/20/2026 at 19:57 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Illumina Inc. stock (ISIN US4523271090) closed at USD 239.62 on September 18, 2026, with a market capitalization of USD 36.18 billion and volume of 32.51 million shares.
Guidance moved higher
According to Yahoo Finance, Illumina reported adjusted EPS of USD 1.31 in Q2 2026 on revenue of USD 1.16 billion, and management lifted full-year guidance to USD 5.30 to USD 5.40 in adjusted EPS on September 20, 2026. The same report says revenue rose 9.5 percent year over year, a comparison that gives the stock its main valuation backdrop.
MarketBeat listed the shares at USD 239.62, a 52-week range of USD 88.00 to USD 250.06, and a consensus price target of USD 199.13 on September 20, 2026. That leaves the stock 16.9 percent above the average target and close to the top of the yearly band.
Analysts still lag price
Illumina stock also carried 18 analysts in MarketBeat's coverage set, with a hold consensus and no strong buy ratings in the snapshot published on September 20, 2026. The contrast between the USD 239.62 quote and the USD 199.13 target shows how far the market has moved ahead of the Street average.
Key trading level
The stock closed at USD 239.62 on September 18, 2026, down 2.27 percent from the prior close of USD 245.18. With a 52-week low of USD 88.00 and a high of USD 250.06, Illumina sits near the upper end of its annual range.
Illumina stock at a glance
- Company: Illumina Inc.
- ISIN: US4523271090
- Ticker: ILMN
- Trading venue: Nasdaq
- Price (as of September 18, 2026, 4:00 PM): USD 239.62
- Market capitalization: USD 36.18 billion (as of September 20, 2026)
- Sector / Industry: Health Care / Life Sciences Tools & Services
- Index membership: S&P 500
